Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Fish and Richardson
Teva
Federal Trade Commission
Daiichi Sankyo
AstraZeneca
McKinsey
Harvard Business School
Colorcon

Generated: April 25, 2018

DrugPatentWatch Database Preview

Zydus Pharms Usa Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ZYDUS PHARMS USA INC, and when can generic versions of ZYDUS PHARMS USA INC drugs launch?

ZYDUS PHARMS USA INC has one hundred and thirty-four approved drugs.

There is one US patent protecting ZYDUS PHARMS USA INC drugs. There are eight tentative approvals on ZYDUS PHARMS USA INC drugs.

There are two patent family members on ZYDUS PHARMS USA INC drugs in two countries and one hundred and eighty-five supplementary protection certificates in twelve countries.

Summary for Zydus Pharms Usa Inc
International Patents:2
US Patents:1
Tradenames:116
Ingredients:116
NDAs:134

Drugs and US Patents for Zydus Pharms Usa Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc GLYBURIDE glyburide TABLET;ORAL 206749-003 May 10, 2016 AB1 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Zydus Pharms Usa Inc NADOLOL nadolol TABLET;ORAL 207761-002 Jul 28, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Zydus Pharms Usa Inc TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 205253-002 Oct 10, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Zydus Pharms Usa Inc RISPERIDONE risperidone TABLET;ORAL 078040-006 Oct 16, 2008 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ZYDUS PHARMS USA INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03

Non-Orange Book US Patents for Zydus Pharms Usa Inc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,139,527 Method of preparation of pitavastatin and pharmaceutical acceptable salts thereof ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for Zydus Pharms Usa Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
90007 Netherlands ➤ Try a Free Trial PRODUCT NAME: TELMISARTAN, DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH VERDRAAGBAAR ZOUT; REGISTRATION NO/DATE: EU/1/98/089/001-EU/1/98/089/010 19981211
/2006 Austria ➤ Try a Free Trial PRODUCT NAME: ENTECAVIR UND DESSEN HYDRATE; REGISTRATION NO/DATE: EU/1/06/343/001- EU/1/06/343/005 20060626
C0033 France ➤ Try a Free Trial PRODUCT NAME: ALISKIRENE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE E CELUI-CI, AMLODIPINE OU SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI, ET HYDROCHLOROTHIAZIDE OU SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; NAT. REGISTRATION NO/DATE: EU/1/11/730/001 20111122; FIRST REGISTRATION: 6167801 20110705
C/GB98/047 United Kingdom ➤ Try a Free Trial PRODUCT NAME: COMBINATIONS OF RAMIPRIL, OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, AND FELODIPINE, OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF.; REGISTERED: SE 13596 19970919; SE 13597 19970919; UK 00017/0402 19980825; UK 00017/0403 19980825
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Dow
Cerilliant
Queensland Health
Medtronic
AstraZeneca
Fuji
Citi
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.